DoW Joint Warfighter Medical, Military Medical Research and Development Award
Agency: Defense Health Agency Contracting Activity - DHACA
- 12.420 -- Military Medical Research and Development
Closed opportunityLast Updated: Jun 17, 2026
Important dates
- Closed: November 16, 2026
Award details
- Expected project funding: $8,800,000
- Expected awards: 4
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:HT942526JWMRPMMRDA
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Grant
- Other
- Procurement contract
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Science technology and other research and development
- Category Explanation:Not specified
History
- Posted date: June 17, 2026
- Archive date: December 16, 2026
- Version: 1
Summary
Jump to documentsSummary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical continuation of previous Department of War (DOW)-funded research and development efforts relevant to the FY26 JWMRP that augment and accelerate high-priority medical requirements to meet the needs of Service Members and other Military Health System beneficiaries. The MMRDA supports a wide range of research projects spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, translational, and clinical research. Projects must be relevant to at least one of the FY26 JWMRP focus areas.
Distinctive Features:
To be eligible for JWMRP funding, applicants/offerors must have already received DOD/DOW core or DOD/DOW Congressional Special Interest funding.
An MMRDA Clinical Research or Clinical Trial Option (MMRDA-CRCTO) is available to specifically support clinical research/observational studies, all phases of clinical trials/interventional studies, and/or correlative studies in support of the development of promising pharmaceutical or biologic candidates, medical devices and technologies. Applicants/offerors should select MMRDA-CRCTO when the application/proposal involves research that includes any human subjects, human biological samples (prospective or retrospective) or human data sets. Note: If selecting this option, applicants must submit additional relevant application/proposal materials.
Eligibility
Miscellaneous
- Unrestricted
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| HT942526JWMRPMMRDA_GG2.pdf | FY26 JWMRP MMRDA Broad Agency Announcement | Jun 24, 2026 08:13 PM UTC |
Agency contact information
Email: help@eBRAP.org
eBRAP Help Desk
Link to additional information
No additional information is available
